Agency of the United States Department of Health and Human Services
POPULARITY
Categories
357 episodes with fda
281 episodes with fda
183 episodes with fda
247 episodes with fda
229 episodes with fda
126 episodes with fda
183 episodes with fda
112 episodes with fda
147 episodes with fda
150 episodes with fda
273 episodes with fda
183 episodes with fda
178 episodes with fda
185 episodes with fda
53 episodes with fda
82 episodes with fda
75 episodes with fda
90 episodes with fda
65 episodes with fda
62 episodes with fda
135 episodes with fda
55 episodes with fda
70 episodes with fda
107 episodes with fda
107 episodes with fda
61 episodes with fda
68 episodes with fda
36 episodes with fda
96 episodes with fda
44 episodes with fda
50 episodes with fda
65 episodes with fda
44 episodes with fda
42 episodes with fda
105 episodes with fda
43 episodes with fda
64 episodes with fda
50 episodes with fda
47 episodes with fda
51 episodes with fda
61 episodes with fda
97 episodes with fda
78 episodes with fda
41 episodes with fda
38 episodes with fda
59 episodes with fda
64 episodes with fda
56 episodes with fda
55 episodes with fda
97 episodes with fda
73 episodes with fda
59 episodes with fda
49 episodes with fda
99 episodes with fda
On this episode, Jason and Matt are joined by their close friend Luis Fernando Mises, along with Jennifer Gillis and Misty Brown, two tireless advocates with the American Kratom Association. Together, we dive deep into the criminalization of kratom — from Louisiana's looming ban to the federal government's quiet war on natural medicine. Luis Fernando Mises is a consultant who teaches leadership across the U.S., a yoga and meditation teacher, a student of Austrian economics, a statesman with the Libertarian Party, a curandero, an entrepreneur, and a family man. He also runs a successful kratom business and brings rare clarity on both the plant and the marketplace. Misty Brown is a fierce kratom advocate and consumer who uses her voice to protect whole-leaf kratom and keep it legal and safe. Her work is personal — helping others fight addiction, chronic pain, anxiety, and depression. Jennifer Gillis has lived with chronic pain for 19 years. After finding real relief through kratom six years ago, she became a dedicated advocate, educator, and truth-teller who supports efforts to keep kratom accessible for all. We begin with the Louisiana ban, where Misty reveals troubling claims of bribery between a sheriff and a rehab clinic pushing the ban behind closed doors. From there, we move to the federal level — breaking down the media's obsession with 7-OH (a lab-concentrated alkaloid being falsely labeled as “kratom”) and how it's fueling disinformation, addiction, and panic. Luis gives clear and grounded advice on avoiding dangerous gas station extracts and choosing safe, whole-leaf kratom instead. We then explore the FDA's alliance with Big Pharma, RFK Jr.'s recent crackdown on 7-OH, and how this could pave the way for a nationwide ban. We dive into Scott Gottlieb's ties to GlaxoSmithKline, the push for synthetic patents, and the blatant monopolization of nature. Then we bring it home with a hard look at the horrors of prohibition through the heartbreaking stories of Shaina Brown and Marshall Price, two innocent people whose lives were upended — and in one case, ended — over this plant. We close with each guest offering real solutions and a final word of encouragement to the millions of Americans who use kratom safely, responsibly, and with purpose. This is a must-listen for anyone who cares about bodily autonomy, plant medicine, and the rising tide of pharmaceutical control. (Length: 1:08:44) Donate/Subscribe to TFTP: https://tftpsubdomain.wpengine.com/tftp-membership/ Jason's 'Know Your Right's 1-Hour Online Seminar: https://www.jasonbassler.com/book-online Sign the petition: https://www.protectkratom.org/ American Kratom Association: https://www.americankratom.org/ Facebook: https://www.facebook.com/emancipatedhumanWebsite: https://emancipatedhuman.com/Kratom: https://bestdamnkratom.com/Contact Luis at his Website Here: https://luisfernandomises.com/
In first-ever study, keto diet scores vs. Parkinson's; Walk away from dementia; Loneliness can kill, but negative social ties can hasten biological aging; Researchers isolate potent memory compound from sage, rosemary; Sketchy knockoff weight loss drugs are flooding the marketplace; The popular vitamin you shouldn't take for sarcoidosis; When osteoporosis is so severe that even minor trauma causes rib fractures.
Struggling with Burnout, Exhaustion, or Stress - Get 1-to-1 support here: https://ra.takeadeepbreath.co.uk/book-a-callToday's guest is Dr. David Smith, a physician & inventor who has spent 14 years studying nature's most impact-resistant creatures to solve traumatic brain injury. He's the creator of the FDA-authorized Q-Collar and revolutionary CO2 rebreather technology that could transform how we prevent brain injuries, treat sleep apnea, and manage altitude sickness. In this podcast we cover his groundbreaking "SLOSH Theory," why people die on Mount Everest, the controversial truth about CO2 levels, and how he brought a clinically brain-dead patient back to consciousness using CO2 therapy.Connect with Dr Dave here: https://davidsmithmd.com/Get The Best Night's Sleep with RA Optics, use this link to get 10% off: https://www.raoptics.com/TADB100:00 Introduction - Meet Dr. Dave0:32 What Is Brain Injury & Slosh Theory?2:45 How CO2 Controls Blood Flow To Your Brain5:02 The Secret Power Of Yawning6:13 CO2 Levels Have Dropped Throughout History8:23 Do Apes Get Concussions Like Humans?10:33 Why People Die On Mount Everest15:29 80 Breaths Per Minute On Everest!16:42 How Do We Know These Respiratory Rates?17:35 What About The Sherpas?22:06 Your Sinuses Are CO2 Storage Tanks22:26 The 2,3-DPG Molecule Explained25:38 Why Altitude Pills Don't Work27:10 How Much Dead Space Do We Have?28:57 The Burping At Altitude Theory33:17 Dead Space From Nose To Lungs44:25 SIDS Theory - The Nasal Cycle Connection58:05 Revolutionary Sleep Apnea Mask1:08:28 Indoor CO2 Controversy Explained1:17:04 Bringing Back The Brain Dead1:25:43 Why CO2 Reverses Brain Death1:27:51 Earthing & Grounding Discussion1:33:32 Where To Find Dr. Dave's Book
Two-time Emmy and Three-time NAACP Image Award-winning, television Executive Producer Rushion McDonald interviewed Dr. Melanye Maclin (Dr. Mac). A celebrity dermatologist and founder of Innovative Hair Technology. Dr. Mac shares her journey of balancing motherhood, caregiving, and entrepreneurship, while passionately advocating for health awareness in the Black community—especially regarding the dangers of chemical hair straighteners. The episode is both inspirational and educational, highlighting resilience, purpose, and the importance of inner and outer wellness.
Two-time Emmy and Three-time NAACP Image Award-winning, television Executive Producer Rushion McDonald interviewed Dr. Melanye Maclin (Dr. Mac). A celebrity dermatologist and founder of Innovative Hair Technology. Dr. Mac shares her journey of balancing motherhood, caregiving, and entrepreneurship, while passionately advocating for health awareness in the Black community—especially regarding the dangers of chemical hair straighteners. The episode is both inspirational and educational, highlighting resilience, purpose, and the importance of inner and outer wellness.
Three of our favorite segments from the week, in case you missed them.Private Insurers Cover Drugs Less Often Now (First) | Fires, Floods, Air Quality & Climate Change (Starts at :24) | 'Cane Sugar' vs High Fructose Corn Syrup (Starts at :59)If you don't subscribe to the Brian Lehrer Show on iTunes, you can do that here.
Nurses Out Loud – In this episode, we tie up loose ends on Zantac's cancer link and expose the ongoing coverup, drawing striking parallels with the Vioxx scandal. We discuss FDA failures, media involvement, processed meats and cancer, and share alternatives like Betaine HCl. Join us as we question pharma's priorities and challenge faith in our federal institutions...
On this episode of Vitality Radio, Jared shares a personal story about his battle with tendonitis and the natural joint supplement that surprised even him with rapid, lasting relief. If you suffer from tendon or ligament issues like tennis elbow, joint pain, or even osteoarthritis, this show is a must-listen. Jared dives deep into the science behind Omne Diem's Connective Tissue TLC, highlighting how three targeted ingredients stimulate fibroblasts, increase elastin, and slow cartilage breakdown. You'll also hear about the joint-lubricating benefits of Baxyl®, a bioidentical hyaluronic acid that Jared calls his go-to for arthritis support. Whether you're an athlete, weekend warrior, or just want to protect your joints as you age, this episode will give you a natural edge.Products:Omne Diem Connective Tissue TLCBaxyl® Hyaluronic AcidOmega-3MSMCuramedCBD - Call to order 801.292.6662Visit the podcast website here: VitalityRadio.comYou can follow @vitalitynutritionbountiful and @vitalityradio on Instagram, or Vitality Radio and Vitality Nutrition on Facebook. Join us also in the Vitality Radio Podcast Listener Community on Facebook. Shop the products that Jared mentions at vitalitynutrition.com. Let us know your thoughts about this episode using the hashtag #vitalityradio and please rate and review us on Apple Podcasts. Thank you!Just a reminder that this podcast is for educational purposes only. The FDA has not evaluated the podcast. The information is not intended to diagnose, treat, cure, or prevent any disease. The advice given is not intended to replace the advice of your medical professional.
Two-time Emmy and Three-time NAACP Image Award-winning, television Executive Producer Rushion McDonald interviewed Dr. Melanye Maclin (Dr. Mac). A celebrity dermatologist and founder of Innovative Hair Technology. Dr. Mac shares her journey of balancing motherhood, caregiving, and entrepreneurship, while passionately advocating for health awareness in the Black community—especially regarding the dangers of chemical hair straighteners. The episode is both inspirational and educational, highlighting resilience, purpose, and the importance of inner and outer wellness.
Nurses Out Loud – In this episode, we tie up loose ends on Zantac's cancer link and expose the ongoing coverup, drawing striking parallels with the Vioxx scandal. We discuss FDA failures, media involvement, processed meats and cancer, and share alternatives like Betaine HCl. Join us as we question pharma's priorities and challenge faith in our federal institutions...
The new U.S.–EU trade deal negotiated between Donald Trump and the EU's Ursula von der Leyen is surprisingly one-sided in favor of the United States. In the end Europe made major concessions, including accepting a 15% tariff on goods and agreeing to purchase $750 billion worth of U.S. energy, while the U.S. gave up virtually nothing in return. Although European leaders were unhappy with the deal, they accepted it to avoid a full-blown trade war, with critics like former Belgian Prime Minister Guy Verhofstadt calling it disastrous and poorly negotiated. Jimmy argues that Europe weakened its own position by severing energy ties with Russia and becoming dependent on U.S. energy and defense, effectively allowing Trump to dictate the terms. He and Americans' Comedian Kurt Metzger conclude that European leaders have sold out their own nations' interests to serve U.S. and transnational elite agendas, leaving their populations economically disadvantaged and politically powerless. Plus segments with Children's Health Defense CEO Mary Holland on the newly confirmed CDC head and the surprise departure of Dr. Vinay Prasad from the FDA, and a closing segment on rocker Dave Matthews' recent statement of support for Palestine. Also featuring Stef Zamorano!
It's In the News.. a look at the top headlines and stories in the diabetes community. This week's top stories: FDA approves the first fast-acting biosimilar insulin in the US, Tandem issues warning, DOJ stands up for remote monitoring in schools, GLP1 use protects against dementia, and more! Find out more about Moms' Night Out Please visit our Sponsors & Partners - they help make the show possible! Learn more about Gvoke Glucagon Gvoke HypoPen® (glucagon injection): Glucagon Injection For Very Low Blood Sugar (gvokeglucagon.com) Omnipod - Simplify Life Learn about Dexcom Check out VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Twitter Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com Reach out with questions or comments: info@diabetes-connections.com Episode transcription with links: Hello and welcome to Diabetes Connections In the News! I'm Stacey Simms and every other Friday I bring you a short episode with the top diabetes stories and headlines happening now. XX We've got the first and only biosimilar FDA approved and moving to market. Kirsty – insulin aspart, which is a biosimilar to Novolog will be available as a single-patient-use prefilled pen for subcutaneous use and a multiple-dose vial for subcutaneous and intravenous use. KIRSTY has been available in Europe and Canada since 2022. This same company makes Semglee, the first biosimilar for long acting? Sales of Insulin Aspart in the United States were approximately $1.9 billion in 2024, according to IQVIA. https://www.globenewswire.com/news-release/2025/07/15/3115973/0/en/Biocon-Biologics-Expands-Diabetes-Portfolio-with-FDA-Approval-of-Kirsty-the-First-and-Only-Interchangeable-Rapid-Acting-Insulin-Aspart-in-the-United-States.html XX Tandem Diabetes Care (Nasdaq:TNDM) has issued an urgent medical device correction for some t:slim X2 automated insulin pumps. In a July 22 notice, the San Diego-based company warned of pumps that may exhibit a higher rate of speaker failure. During normal use, the insulin pump software monitors current flowing through the speaker during use. Measurements that fall within a pre-determined range indicate a functioning speaker. Meanwhile, measurements falling outside the range indicate a speaker failure. When the measurements land outside the expected range, the system declares a malfunction, referred to as “Malfunction 16.” If the pump declares this malfunction, insulin delivery will stop and the pump will no longer be operational. Malfunction 16 terminates communication between the pump and continuous glucose monitor (CGM), as well as the t:slim mobile app. If not addressed, the issue can lead to hyperglycemia, which can result in hospitalization or medical intervention. The company reports 700 adverse events and 59 reported injuries to date, with no reports of death. Tandem identified that certain speaker versions have a higher rate of Malfunction 16 events due to a wiring issue within the speaker. Users can continue using their pump but with added precautions because Malfunction 16 can occur at any time. They should use the t:slim mobile app with push notifications turned on so the app alerts them if the malfunction occurs, the company said. Additionally, Tandem intends to release a software update aimed at enhancing the early detection of speaker failure. The update also introduces persistent vibration alarms to help reduce potential safety risk. Tandem plans to notify affected pump users when it makes the update available. https://www.drugdeliverybusiness.com/tandem-warns-insulin-pump-speaker-malfunction/ XX BIG WIN! The DOJ protects T1D rights again! The US Attorney's office for the Western District of Washington State reached a settlement with a public school district that once again confirms remotely monitoring students' CGMs is a reasonable accommodation that schools must provide to comply with the Americans with Disabilities Act. If its true for one state its true for all states under federal law! If your local schools still refuse to remotely monitor CGMs of their students, provide them with this letter to compel them to FOLLOWT1Ds and FOLLOW Federal Laws. If they still refuse contact us! https://followt1ds.org/ XX new study finds people taking GLP-1 agonists had a significantly lower cumulative risk of developing dementia, when compared to metformin users. Past studies show that people who have type 2 diabetes — a chronic condition where the body does not use its insulin properly — are at a higher risk of developing dementia. The study found that when comparing the neuroprotective abilities of two diabetes medications — metformin and glucagon-like peptide-1 receptor agonists (GLP-1 agonists) — participants taking GLP-1 agonists had a significantly lower cumulative risk of developing dementia, when compared to metformin. https://www.medicalnewstoday.com/articles/glp-1s-may-offer-better-dementia-protection-than-metformin XX Front office changes coming to Dexcom. CEO Kevin Sayer will step down & give the reins to current Chief Operating Officer Jake Leach. Scheduled for January 1, 2026, Leach will also join Dexcom's board of directors where Sayer will remain executive chairman. One of our frequent guests here.. Leach has worked at Dexcom for 21 years. He served as chief technology officer from 2018 to 2022 before he was named COO in late 2022. He was given the title of president in May. https://www.medtechdive.com/news/dexcom-ceo-change-kevin-sayer-jake-leach/756382/ XX A major international study has revealed that many children and young adults in Sub-Saharan Africa who are diagnosed with type 1 diabetes (T1D) may actually have a different, non-immune-based form of the condition. Unlike the traditional autoimmune version of T1D, this form appears to develop without the immune system attacking the insulin-producing cells. This finding could significantly reshape how diabetes is diagnosed and treated across the region, potentially leading to more precise care and better health outcomes. The researchers found that many young people in Sub-Saharan Africa diagnosed with T1D often don't have the usual markers in their blood (called islet autoantibodies) typically seen in people with T1D in other parts of the world. Specifically, 65% of participants with T1D in this region did not have islet autoantibodies. When the researchers compared this data to studies in the U.S., they found a smaller but significant proportion (15%) of Black participants diagnosed with T1D had a similar form of diabetes found in Sub-Saharan Africa – characterized by negative autoantibodies and a low T1D genetic risk score. However, white Americans with T1D showed the typical autoimmune pattern, even if they didn't have detectable autoantibodies, their genetics still pointed to autoimmune diabetes. “The identification of this T1D diabetes subtype in Sub-Saharan African populations and among individuals of African ancestry in the U.S. suggests a potential ancestral or genetic link,” Dabelea notes. “These findings highlight the need to consider alternative etiologies in this group and a deeper understanding of the underlying mechanisms may provide important insights for future prevention and treatment strategies.” https://scitechdaily.com/new-diabetes-subtype-discovered-in-africa-challenges-global-assumptions/ XX Formal recognition for the specialty of Diabetology. Diabetology is the specialty focused on the full continuum of diabetes care — encompassing diagnosis, treatment, prevention, technology integration, education, and cardiometabolic management. While it intersects with endocrinology, primary care, and public health, diabetology is uniquely defined by its depth and focus on diabetes alone. The American College of Diabetology (ACD) is the national professional organization representing clinicians who specialize in diabetes care. ACD advances clinical excellence and education to improve the lives of those affected by diabetes. https://www.businesswire.com/news/home/20250725766248/en/American-College-of-Diabetology-Announces-Formal-Taxonomy-Classification-for-Diabetology XX Tidepool announces cloud-to-cloud integration with Abbott's FreeStyle Libre portfolio. From the release: This integration allows people living with diabetes using the FreeStyle Libre portfolio to connect their data to their Tidepool account seamlessly. For healthcare providers, this means more comprehensive insights and streamlined workflows, with FreeStyle Libre systems data flowing continuously into the Tidepool Data Platform. https://www.tidepool.org/blog/abbott-freestyle-libre-integration-launched XX Stelo dexom ai food XX With high drug prices remaining an ongoing concern for U.S. politicians, Roche is considering following in the footsteps of some of its peers with a direct-to-consumer (DTC) model to cut out the middlemen. About 50% of the money spent on drugs in the U.S. healthcare system goes straight to PBMs instead of the companies that create the medicines, Roche CEO Thomas Schinecker called out in a press conference on Thursday. Bringing the drugs directly to the consumer could be a solution to positively impact pricing for patients “without destroying innovation,” Schinecker added on a separate Thursday call with investors, noting that the company has discussed the matter with the U.S. government and its Department of Health and Human Services. The pricing talks come after President Donald Trump inked a “Most Favored Nation” executive order in May, aiming to tie U.S. drug prices to lower prices in other developed nations. The plan was quickly called out by industry voices such as the PhRMA trade group, which labeled it a “bad deal” for U.S. patients. https://www.fiercepharma.com/pharma/roche-weighing-direct-consumer-drug-sales-ease-us-drug-pricing-woes-cut-out-pbms-ceo-says XX SAB BIO secures substantial $175M financing to advance T1D therapy with impressive investor lineup and extended cash runway until 2028. Most critically, this financing fully funds the pivotal Phase 2b SAFEGUARD study evaluating SAB-142 for delaying progression of autoimmune Type 1 diabetes in newly diagnosed patients. By extending the cash runway into mid-2028, SAB has effectively eliminated near-term financing risk and provided clear visibility through this crucial clinical trial and potential commercialization preparation. Participation from strategic investor Sanofi, along with new investors RA Capital Management, Commodore Capital, Vivo Capital, Blackstone Multi-Asset Investing, Spruce Street Capital, Forge Life Science Partners and Woodline Partners LP, and existing investors Sessa Capital, the T1D Fund, and ATW Partners https://www.stocktitan.net/news/SABS/sab-bio-announces-oversubscribed-175-million-private-fwsf2t91ek4z.html XX In a landmark 14-year study, researchers have found that artificially sweetened drinks raise the risk of developing type 2 diabetes by more than a third, significantly higher than those loaded with sugar. It challenges the long-standing perception of diet drinks being a healthier alternative and suggests they may carry metabolic risks of their own. In the first longitudinal study of its kind, led by Monash University, researchers tracked 36,608 participants over an average period of 13.9 years to assess how both sugar-sweetened beverages (SSBs) and artificially sweetened beverages (ASBs) impacted health outcomes. The self-reported health data, from the Melbourne Collaborative Cohort Study, was drawn from participants aged 40 to 69 years at the time of recruitment. What they found was that drinking just one can of artificially sweetened soda increased the risk of developing type 2 diabetes by 38%, compared to people who didn't consume these drinks at all. For those consuming the same amount of sugary drinks, the risk was 23% higher. This suggests there's more than obesity at play. The researchers believe this result is due to an independent metabolic effect, possibly gut microbiome disruption or a change in glucose metabolism. While the study didn't identify which artificial sweeteners were at play, Evidence suggests that artificial sweeteners can alter the composition and function of gut bacteria, leading to glucose intolerance – a precursor to type 2 diabetes. And that some sweeteners may trigger insulin release, desensitize metabolic responses over time, or confuse the body's glucose regulation system – even without actual sugar in the picture. Another hypothesis is that regular exposure to the kind of intense sweetness that artificial products deliver may condition the body to anticipate sugar calories that never come, affecting appetite regulation, insulin sensitivity and broader metabolic pathways. However, the authors suggest that how sweeteners affect the gut microbiota and glucose regulation are the most likely drivers of increased diabetes risk. https://newatlas.com/diet-nutrition/one-drink-diabetes-risk/ XX After months of deliberation, information gathering and public testimony, a state board unanimously agreed Monday that two common medications for type-2 diabetes and other conditions appear to pose an affordability challenge to the state and Marylanders. The state Prescription Drug Affordability Board approved two resolutions saying that prescription drugs Jardiance and Farxiga likely pose an “an affordability challenge for the state health care system” and the state should look for ways to bring down those costs. Health care advocates call the long-awaited resolution an “important first step” in the process in bringing down prescription costs for those on the state's health plan. That milestone has been years in the making. Created in 2019 by the General Assembly, the Prescription Drug Affordability Board was slow to launch due in part to a veto from former Gov. Larry Hogan (R) amid pandemic-induced economic uncertainty in 2020 that delayed the board's formation. The board also cited out-of-pocket costs for consumers and state and local spending on those drugs as indicators that there may be an affordability challenge. The board will now look at options to address the potential affordability challenge, which could include setting an upper payment limit on those drugs. But it's not clear when the state will see cost savings. That said, some members of the health care system and the pharmaceutical industry say that policies such as upper payment limits could weaken access to life-saving drugs. Others say that the board has not engaged enough viewpoints from the health care industry. https://marylandmatters.org/2025/07/29/state-board-determines-two-type-2-diabetes-drugs-may-be-unaffordable/ XX One year after it was revealed that Chrissy Teigen and John Legend's son, Miles, was diagnosed with type 1 diabetes, Teigen is revealing how she's making her son feel more included. Teigen first opened up about her 7-year-old son's diagnosis after she and her two oldest kids, Miles and 9-year-old daughter Luna were at the 2024 summer Olympics cheering on Simone Biles. Teigen posted a photo of Miles and Luna holding up a sign. Also visible in the picture was the insulin pump on Miles' arm. Now, Teigen is sharing some insight into how she's making Miles more comfortable with having type 1 diabetes, including giving LeBron James' Barbie doll type 1 diabetes as well. In a video shared on Instagram, Teigen is seen taking the T1D Barbie, removing her insulin pump and gluing the pump onto LeBron James' Barbie. “Turning T1D Barbie into T1D Lebron James for my son,” Teigen captioned the video, revealing James is Miles' hero. 41 million followers https://www.yahoo.com/lifestyle/articles/chrissy-teigen-gives-lebron-james-154608782.html
Ever been killed by coffee? Poisoned by pepper? Drowned by molasses?! Welcome to the most unappetizing episode of the century. In this delightfully unhinged episode of For the Love of History, we're diving into the sticky, deadly, and downright absurd world of food disasters in the early 1900s. From lead-laced milk to spice-rack murder, we explore how everyday foods became instruments of death — all thanks to lack of regulation, industrial negligence, and profit-hungry robber barons.
Dr. Jack Cush reviews the news, journal reports and a new treatment for RA from the FDA.
MedPod Today: the podcast series where MedPage Today reporters share deeper insight into the week's biggest healthcare stories. This week, MedPage Today reporters discuss an FDA official's abrupt exit and the future of USPSTF, a major publishing slowdown at MMWR, and why FDA's so-called 'expert panels' are raising red flags. Episode produced and hosted by Rachael Robertson. Sound engineering by
Today's Headlines: U.S. GDP grew 3% in Q2, beating forecasts and prompting Trump to once again pressure Fed Chair Jerome Powell to cut rates—though the Fed held steady, with only Trump's appointees voting to lower them. Trump also slapped new tariffs on Brazil and India, making everyday imports like coffee and beef 90% pricier. Meanwhile, on the Epstein beat: a source says the prison footage from the night of his death isn't actually missing, and Senator Chuck Schumer invoked the obscure “Rule of Five” to demand DOJ documents—threatening court action if they're not handed over. Elsewhere in Trump-world, his former defense attorney Emil Bove was confirmed to a lifetime federal judgeship despite whistleblower claims of ethics violations and loyalty purges. The DOJ also dropped a major fraud case against Fatburger's parent company after firing the lead prosecutor, raising eyebrows given the chairman's GOP donations. In other headlines: a historic 8.8 earthquake near Russia triggered tsunami warnings across the Pacific; the FDA issued a recall after High Noon hard seltzers were mislabeled as Celsius energy drinks; and Kamala Harris announced she's not running for California governor in 2026, though she hinted at future plans. Resources/Articles mentioned in this episode: CNBC: U.S. economy grew at a 3% rate in Q2, a better-than-expected pace even as Trump's tariffs hit CNBC: Fed holds interest rates steady: What that means for car loans, credit cards, mortgages and more NBC News: Trump hits India and Brazil with high tariffs, lowers South Korea duties CBS News: There was no "missing minute" in the original Epstein jail video, government source says Axios: Democrats invoke rare Senate rule to force release of Epstein documents CBS News: Senate confirms former Trump attorney Emil Bove as U.S. appeals court judge NBC News: DOJ dismisses case against a Trump donor after White House fired career prosecutor AP News: Tsunami evacuations ordered in South America, but worst risk appears to pass for US after huge quake CNN: High Noon issues a recall after selling some vodka seltzer mislabeled as Celsius energy drinks Axios: Kamala Harris won't run for governor in 2026 Morning Announcements is produced by Sami Sage and edited by Grace Hernandez-Johnson Learn more about your ad choices. Visit megaphone.fm/adchoices
President Trump announced a major trade deal with South Korea, securing $350 billion in U.S.-directed investments, $100 billion in energy purchases, and a 15% tariff on Korean goods, while U.S. exports face zero tariffs. U.S. GDP grew 3% in Q2 2025, surpassing expectations, with inflation dropping to 2.1%, prompting optimism from the White House despite the Federal Reserve holding interest rates steady. Nancy Pelosi endorsed a congressional insider trading ban after Trump accused her of profiting from insider knowledge, while a new Stanford study revised COVID vaccine lives saved to 2.5 million globally, far below WHO's 14.4 million estimate. U.S. fertility rates hit a record low of 1.6 children per woman, with a Georgian church-led initiative cited as a model for reversing declines, and Senator Josh Hawley's $600 tariff rebate proposal sparked debate as a morally questionable gimmick. Trump South Korea trade deal, U.S. GDP growth, inflation rate, Josh Hawley, tariff rebates, Nancy Pelosi, insider trading, COVID vaccine study, U.S. fertility rate, Georgian Orthodox Church, Cincinnati violence, Vinay Prasad, FDA
The Trump administration continues to advance the Make America Healthy Again (MAHA) movement. Health and Human Services Secretary Robert F. Kennedy Jr. and FDA Commissioner Dr. Marty Makary are leading the initiative. Dr. Makary joins the Rundown to discuss the dangers of energy drinks and gummies containing opioid-like substances, efforts to remove dyes and chemicals from the nation's food, and how the FDA plans to update America's dietary guidelines. He also addresses some of the controversies surrounding HHS Secretary Kennedy and the MAHA movement. Violent crime has made headlines across the country, fueling public concern even as national statistics show a steady decline. Former U.S. Attorney and Executive Director of Right On Crime Brett Tolman joins the Rundown to explain how stronger border enforcement and deporting criminal illegal immigrants have helped reduce crime and argues that empowering law enforcement can further drive down violence across the country. Plus, commentary from Co-Chair of the Republican National Committee Youth Council, CJ Pearson. Photo Credit: AP Learn more about your ad choices. Visit podcastchoices.com/adchoices
Jennifer Pattison Tuohy joins Mikah Sargent this week on Tech News Weekly! Jennifer shares her first impressions of Alexa Plus. The growing overlap between consumer wellness gadgets and regulated medical technology. And Google's rolling out a machine-learning age verification model to detect account users who are under or over the age of 18. Jennifer Pattison Tuohy has spent some time with Amazon's new, AI-powered Alexa, Alexa Plus. She shares her excitement and criticisms for the new voice assistant. Victoria Song of The Verge joins Mikah to talk about wearable tech companies using the idea of "wellness" technology to skirt FDA regulation on medical technology. And Mikah talks about Google's rollout of a machine-learning age verification model to verify account users' age in the U.S. Hosts: Mikah Sargent and Jennifer Pattison Tuohy Guest: Victoria Song Download or subscribe to Tech News Weekly at https://twit.tv/shows/tech-news-weekly. Join Club TWiT for Ad-Free Podcasts! Support what you love and get ad-free shows, a members-only Discord, and behind-the-scenes access. Join today: https://twit.tv/clubtwit Sponsors: spaceship.com/twit uscloud.com threatlocker.com for Tech News Weekly
Dr. Nick Brüss, EdD, LMFT, is a leading expert in psychedelic-assisted therapy and a licensed therapist. He serves as a clinical researcher and supervisor on the FDA phase III MAPS trial using MDMA for PTSD and is the lead therapist on Compass Pathways' psilocybin trial for treatment-resistant depression. A specialist in Internal Family Systems therapy, Dr. Brüss has shared his work at UCLA and Yale. He's also a certified mindfulness facilitator and Compassion Cultivation teacher, blending science, compassion, and innovation in healing. In This EpisodeNick's websiteYou can learn more about what I do here:The Trauma Therapist Newsletter: celebrates the people and voices in the mental health profession. And it's free! Check it out here: https://bit.ly/4jGBeSaThe Trauma Therapist Podcast: I interview thought-leaders in the fields of trauma, mindfulness, addiction and yoga such as Peter Levine, Pat Ogden, Bessel van der Kolk and Bruce Perry. https://bit.ly/3VRNy8zBecome a supporter of this podcast: https://www.spreaker.com/podcast/the-trauma-therapist--5739761/support.
Jennifer Pattison Tuohy joins Mikah Sargent this week on Tech News Weekly! Jennifer shares her first impressions of Alexa Plus. The growing overlap between consumer wellness gadgets and regulated medical technology. And Google's rolling out a machine-learning age verification model to detect account users who are under or over the age of 18. Jennifer Pattison Tuohy has spent some time with Amazon's new, AI-powered Alexa, Alexa Plus. She shares her excitement and criticisms for the new voice assistant. Victoria Song of The Verge joins Mikah to talk about wearable tech companies using the idea of "wellness" technology to skirt FDA regulation on medical technology. And Mikah talks about Google's rollout of a machine-learning age verification model to verify account users' age in the U.S. Hosts: Mikah Sargent and Jennifer Pattison Tuohy Guest: Victoria Song Download or subscribe to Tech News Weekly at https://twit.tv/shows/tech-news-weekly. Join Club TWiT for Ad-Free Podcasts! Support what you love and get ad-free shows, a members-only Discord, and behind-the-scenes access. Join today: https://twit.tv/clubtwit Sponsors: spaceship.com/twit uscloud.com threatlocker.com for Tech News Weekly
Jennifer Pattison Tuohy joins Mikah Sargent this week on Tech News Weekly! Jennifer shares her first impressions of Alexa Plus. The growing overlap between consumer wellness gadgets and regulated medical technology. And Google's rolling out a machine-learning age verification model to detect account users who are under or over the age of 18. Jennifer Pattison Tuohy has spent some time with Amazon's new, AI-powered Alexa, Alexa Plus. She shares her excitement and criticisms for the new voice assistant. Victoria Song of The Verge joins Mikah to talk about wearable tech companies using the idea of "wellness" technology to skirt FDA regulation on medical technology. And Mikah talks about Google's rollout of a machine-learning age verification model to verify account users' age in the U.S. Hosts: Mikah Sargent and Jennifer Pattison Tuohy Guest: Victoria Song Download or subscribe to Tech News Weekly at https://twit.tv/shows/tech-news-weekly. Join Club TWiT for Ad-Free Podcasts! Support what you love and get ad-free shows, a members-only Discord, and behind-the-scenes access. Join today: https://twit.tv/clubtwit Sponsors: spaceship.com/twit uscloud.com threatlocker.com for Tech News Weekly
Is your nonprofit still buried in paper forms and outdated systems? In this episode, I sit down with Patrick Waldo—AI and SaaS innovator and CEO of Unicorn Forms—to talk about the real risks and opportunities around e-signatures, data security, and going digital. From board agreements to grant paperwork and beyond, we explore how even small nonprofits can make a big leap into smarter, safer, and more accessible systems. If you're tired of chasing signatures and retyping forms, you need this conversation. Episode Highlights 05:20 - E-sign solutions and nonprofit needs 01:16 - Nonprofit Paperwork Challenges with Patrick Waldo 06:27 - E-signatures: Legal Basics & Security 13:14 - Digital Transformation & Real-World Examples 22:48 - Data, Analytics & The Future of Nonprofit Tech Meet the Guest My guest for this episode is Patrick Waldo. Patrick Waldo, CEO, is a seasoned technology leader with over 15 years of experience developing AI/ML and data analytics SaaS solutions adopted by the Fortune 500. As CEO of UnicornForms, Inc., he's on a mission to make paperwork frictionless through innovative form and document management. Previously, he served as VP of Product at Decernis, where he drove product development, led technical due diligence through two PE acquisitions, and secured two patents in AI/ML and NLP. At FoodChain ID, he led post-merger integration strategies, and at Redica Systems, he oversaw FDA analytics and monitoring for the pharmaceutical industry. Waldo holds master's degrees from Carnegie Mellon University and the University of Bologna, with expertise in IT, management, policy, and economics. He holds a Bachelor's degree from Grinnell College. Connect with Patrick: Web: https://www.unicornforms.com LinkedIn: https://www.linkedin.com/company/unicornforms Instagram: http://instagram.com/unicornforms Facebook: http://facebook.com/unicornforms Sponsored Resource Join the Inspired Nonprofit Leadership Newsletter for weekly tips and inspiration for leading your nonprofit! Access it here >> Be sure to subscribe to Inspired Nonprofit Leadership so that you don't miss a single episode, and while you're at it, won't you take a moment to write a short review and rate our show? It would be greatly appreciated! Let us know the topics or questions you would like to hear about in a future episode. You can do that and follow us on LinkedIn.
Jennifer Pattison Tuohy joins Mikah Sargent this week on Tech News Weekly! Jennifer shares her first impressions of Alexa Plus. The growing overlap between consumer wellness gadgets and regulated medical technology. And Google's rolling out a machine-learning age verification model to detect account users who are under or over the age of 18. Jennifer Pattison Tuohy has spent some time with Amazon's new, AI-powered Alexa, Alexa Plus. She shares her excitement and criticisms for the new voice assistant. Victoria Song of The Verge joins Mikah to talk about wearable tech companies using the idea of "wellness" technology to skirt FDA regulation on medical technology. And Mikah talks about Google's rollout of a machine-learning age verification model to verify account users' age in the U.S. Hosts: Mikah Sargent and Jennifer Pattison Tuohy Guest: Victoria Song Download or subscribe to Tech News Weekly at https://twit.tv/shows/tech-news-weekly. Join Club TWiT for Ad-Free Podcasts! Support what you love and get ad-free shows, a members-only Discord, and behind-the-scenes access. Join today: https://twit.tv/clubtwit Sponsors: spaceship.com/twit uscloud.com threatlocker.com for Tech News Weekly
“Pandemics are a political choice. We will not be able to prevent every disease outbreak or epidemic but we can prevent an epidemic from becoming a pandemic,” says Dr. Joanne Liu, the former International President of Médecins Sans Frontières/Doctors Without Borders and a professor in the School of Population and Global Health at McGill University. You are in for a lot of that sort of frank and clear-eyed analysis in this episode of Raise the Line from Dr. Liu, whose perspective is rooted in decades of experience providing medical care on the frontlines of major humanitarian and health crises across the globe, as well as wrangling with world leaders to produce more effective responses to those crises and to stop attacks on medical facilities and aid workers in conflict zones. Firsthand accounts from the bedside to the halls of power are captured in her new book Ebola, Bombs and Migrants, which focuses on the most significant issues during her tenure leading MSF from 2013-2019. The book also contains insights about the geopolitical realities that hamper this work, including lax enforcement of international humanitarian law, and a focus on national security that erodes global solidarity. Join host Lindsey Smith as she interviews this leading voice on our preparedness to meet the needs of those impacted by violent conflict, forced migration, natural disasters, disease outbreaks and other grave challenges. If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/raisethelinepodcast
On the Inside View, we talk to the experts behind the innovations shaping our lives. This week, Andrey Zarur discusses the future of cancer surgery and makes a bold prediction — that we could effectively see the end of cancer within our lifetimes. Zarur, a biochemist and co-founder of Lumicell and GreenLight Biosciences, is on his way to making this prediction a reality. He sits down with Oz to discuss the FDA-approved technology that is helping surgeons see and remove cancer tissue with unprecedented precision. Then, they discuss how Zarur plans to address agriculture’s pest problem, without using chemical pesticides.See omnystudio.com/listener for privacy information.
A massive 8.8-magnitude earthquake off Russia's Kamchatka Peninsula triggers tsunami warnings for Hawaii, Alaska, and the U.S. West Coast, with Japan's Pacific coast expecting waves up to 3 yards. The quake, the largest since 2011, causes minor damage in Russia. The Senate confirms Trump's DOJ nominee Emil Bove as a federal judge in a 50-49 vote. Dr. Vinay Prasad resigns from the FDA after facing Big Pharma backlash. Trump reflects on sparing Hillary Clinton from prosecution, contrasting it with the Russiagate hoax. Ron DeSantis criticizes H-1B visa abuse, and ICE arrests a Jamaican overstaying his visa, hired as a Maine police officer. Senator Josh Hawley proposes $600 tariff rebates for Americans. Job vacancies drop to 7.4 million. Tsunami warning, Kamchatka earthquake, Shane Tamura, Manhattan shooting, emil Bove, Vinay Prasad, Trump administration, Ron DeSantis, H-1B visas, Josh Hawley, tariff rebates, economy
The morning after the FDA's vaccine regulator Dr. Vinay Prasad announced his resignation, FDA Commissioner Dr. Marty Makary shares the agency's position on the measles vaccine, Sarepta's Duchenne therapy, and the addictive kratom-derived compound OH-7. Booking Holdings CEO Glenn Fogel discusses the impact of geopolitics on travel to the U.S. While Canadians and Europeans are still traveling, the operator of Agoda, Priceline, and Kayak says they're going to Mexico and Asia, instead of the U.S. Plus, Wall Street remembers the lives lost in Monday's shooting, the first tsunami waves from Russia's 8.8 earthquake have hit Hawaii's shores, and CNBC's Eamon Javers reports on his conversation with Treasury Secretary Scott Bessent about trade talks with China. Eamon Javers - 07:24Dr. Marty Makary - 18:51Glenn Fogel - 36:48 In this episode:Eamon Javers, @EamonJaversJoe Kernen, @JoeSquawk Becky Quick, @BeckyQuickAndrew Ross Sorkin, @andrewrsorkinKatie Kramer, @Kramer_Katie
On this episode of Vitality Radio, Jared dives into part two of his Biocidin discussion, offering a clear and practical guide to using Biocidin and complementary supplements for a full-body microbiome reset. After an enlightening interview with Dr. Shawn Manske, Jared returns to clarify the most common questions: how to dose Biocidin, how long to use it, what to pair it with, and how to tailor protocols for specific needs like SIBO, Candida, SIFO, chronic infections like lyme, and oral microbiome health. Whether you're experiencing bloating, brain fog, bad breath, or gum sensitivity—or just want to clean the slate and reset your gut—this episode is packed with real-world protocols and user-friendly strategies. Jared outlines how to layer in binders, spore probiotics, and enzymes, and shares effective oral care routines. He even covers options for children and the highly sensitive. This episode is your comprehensive roadmap for restoring microbial balance, enhancing immune and digestive function, and promoting vitality from the gut to the gums.Products DiscussedSolaray MycroBiome Formulas (Vitality Radio POW! Product of the Week PROMO CODE: POW2)Visit the podcast website here: VitalityRadio.comYou can follow @vitalitynutritionbountiful and @vitalityradio on Instagram, or Vitality Radio and Vitality Nutrition on Facebook. Join us also in the Vitality Radio Podcast Listener Community on Facebook. Shop the products that Jared mentions at vitalitynutrition.com. Let us know your thoughts about this episode using the hashtag #vitalityradio and please rate and review us on Apple Podcasts. Thank you!Just a reminder that this podcast is for educational purposes only. The FDA has not evaluated the podcast. The information is not intended to diagnose, treat, cure, or prevent any disease. The advice given is not intended to replace the advice of your medical professional.
(July 30, 2025)Ghislane Maxwell wants immunity before she will testify to Congress. EPA to revoke “endangerment finding,” landmark basis for regulating greenhouse gases. Dr. Jim Keany, Chief Medical Officer at Dignity Health St. Mary Medical Center in Long Beach, joins The Bill Handel Show for 'Medical News'! Dr. Keany talks with Bill about a study that has shown The Pandemic aged our brains faster, how many steps you need daily to combat diabetes, and prescription fluoride facing FDA scrutiny.
We're running another ACX Grants round! If you already know what this is and just want to apply for a grant, use the form here (should take 15 - 30 minutes), deadline August 15. If you already know what this is and want to help as a funder, VC, partner charity, evaluator, or friendly professional, click the link for the relevant form, same deadline. Otherwise see below for more information. What is ACX Grants? ACX Grants is a microgrants program that helps fund ACX readers' charitable or scientific projects. Click the links to see the 2022 and 2024 cohorts. The program is conducted in partnership with Manifund, a charity spinoff of Manifold Markets, who handle the administrative/infrastructure side of things. How much money is involved? I plan to contribute $200K. I expect (but cannot guarantee) an additional $800K from other donors, for a total of about $1 million. Most grants will probably be between $5,000 and $50,000, with a rare few up to $100,000. Depending on how much external donor interest there is, we will probably give between 10 and 50 grants. What's the catch? There's no catch, but this year we plan to experiment with replacing some grants with SAFEs, and others with convertible grants. That means that if you're a startup, we (ACX Grants as an nonprofit institution, not me personally) get some claim to future equity if you succeed. If you're not a startup, you'll sign an agreement saying that if your project ever becomes a startup, then we'll get the equity claim. We're still working on the exact details of this agreement, but we intend to have pretty standard terms and err in the favorable-to-you direction; obviously we'll show you the final agreement before you sign anything. We're doing this because some of our previous grantees became valuable companies, and it seems foolish to leave that money on the table when we could be capturing it and reinvesting it into future grants rounds. Please don't let this affect your decision to apply. Our top priority remains charity, and we'll continue to select grantees based on their philanthropic value and not on their likelihood of making us money. If you're not a startup and don't plan to become one, none of this should affect you. And if you have a good reason not to want to sign these agreements - including “I'm not savvy enough to know what this means and it makes me nervous” - then we're happy to opt you out of them. What's the timeline? We'd like to have grants awarded by October 1 and money in your hands by November 1. This is a goal, not a promise. What will the application process be like? You fill out a form that should take 15 - 30 minutes. If we have questions, an evaluator might email or call you, in a way that hopefully won't take more than another 15 - 30 minutes of your time to answer. If you win a grant, Manifund will send you the money, probably by bank wire. Every few years, we might ask you to fill out another 15 - 30 minute form letting us know how your project is doing. What kind of projects might you fund? There are already lots of good charities that help people directly at scale, for example Against Malaria Foundation (which distributes malaria-preventing bed nets) and GiveDirectly (which gives money directly to very poor people in Africa). These are hard to beat. We're most interested in charities that pursue novel ways to change complex systems, either through technological breakthroughs, new social institutions, or targeted political change. Among the projects we've funded in the past were: Development of oxfendazole, a drug for treating parasitic worms in developing countries. A platform that lets people create prediction markets on topics of their choice A trip to Nigeria for college students researching lead poisoning prevention. A group of lawyers who sue factory farms under animal cruelty laws. Development of software that helps the FDA run better drug trials. A startup building anti-mosquito drones to fight tropical disease A guide for would-be parents on which IVF clinics have the highest successful rate of successful implantation. A university lab working on artificial kidneys You can read the full list here and here, and the most recent updates from each project here. Is there anything good about winning an ACX Grant other than getting money? You'll get my support, which is mostly useful in getting me to blog about your project. For example, I can put out updates or requests for help on Open Threads. I can also try to help connect you to people I know. Some people who won ACX Grants last year were able to leverage the attention to attract larger grantmakers or VCs. You can try to pitch me guest posts about your project. This could be a description of what you're doing and why, or just a narrative about your experience and what you learned from it. Warning that I'm terrible to pitch guest posts to, I almost never go through with this, and I'm very nitpicky when I do. Still, you can try. We're working on gathering a network of friendly professionals who agree to provide pro bono or heavily discounted support (eg legal, accounting, business advice, cloud compute) to ACX grantees. We've only just begun this process and it might not actually materialize. There are occasional virtual and physical meetups of ACX grantees; these don't always result in Important Professional Connections, but are pretty interesting. What if I want those nonfinancial benefits for my project, but don't need money? Apply for a grant of $1. But we're pretty nervous about giving very-low-cost grants because it's too easy to accept all of them and dilute our signaling value; for this reason, it might be harder to get a grant of $1 than a grant of $5,000, and we expect these to make up only 0 - 10% of our cohort. You might be better off coming up with some expansion of your project that takes $5,000 and applying for that. What are the tax implications of an ACX Grant? Consult your accountant, especially if you live outside the US. If you live inside the US, we think it's ordinary taxable income. If you're an individual, you'll have to pay taxes on it at your usual tax rate. If you're a 501(c), you'll get your normal level of tax exemption. I want to fund you, how can I help? For bureaucratic reasons, we're currently looking for donations mostly in the $5,000+ range. If that's you, fill out the Funder Application Form. If we've already talked about this over email, you don't need to fill out the form, but we encourage you to do so anyway so we know more about your interests and needs. What's the story behind why you have $200K to spend on grants every year, but are still asking for more funding? Some generous readers sent me crypto during the crypto boom, or advised me on buying crypto, or asked to purchase NFTs of my post for crypto. Some of the crypto went up. Then I reinvested it into AI stocks, and those went up too. I think of this as unearned money and want to give some of it back to the community, hence this grants program. I have a lot of it but not an unlimited amount. At the current rate, I can probably afford another ~5 ACX Grants rounds. When it runs out, I‘ll just be a normal person with normal amounts of money (Substack is great, but not great enough for me to afford this level of donation consistently). My hope is that I can keep making these medium-sized donations, other people can add more to the pot, and we'll be able to drag this out at least five more rounds, after which point maybe we'll come up with another plan. I'm a VC, how can I help? Some of our applicants are potentially-profitable startups, and we decide they're a better match for VC funding than for our grants. If you're willing to look these over and get in touch with any that seem interesting, fill out the VC Application Form. It will ask for more information on what kind of opportunities you're interested in funding. I'm a philanthropist or work at a philanthropic foundation; how can I help? Some of our applicants are good projects, but not a good match for us, and we want to shop them around to other philanthropists and charities who might have different strengths or be able to work with larger amounts of money. If that's you, please fill out the Partner Charity Application Form I'm good at evaluating grants, or an expert in some specific field; how can I help? If you have experience as a grantmaker or VC, or you're an expert in some technical field, you might be able to help us evaluate proposals. Fill out the Evaluator Application Form. By default we expect you'll want us to send you one or two grants in your area of expertise, but if you want a challenge you can request more. If we've already talked about this over email, you don't need to fill out the form, but we encourage you to do so anyway so I know more about your interests and needs. We expect to get more volunteers than we need, and most people who fill in the evaluator form won't get contacted unless we need someone from their specific field. I'm a professional who wants to do pro bono work for cool charities, how can I help? Fill out the Friendly Professional Application Form. If we get enough applicants, we'll compile them into a directory for our grantees. I participated in the Impact Certificate Market last year, did you forget about me? Yes until Austin Chen reminded me last month No! Request final oracular funding by filling in the Impact Applicant Form. Sorry, I forgot, where do I go to apply for a grant again? See form here. Please apply by 11:59 PM on August 15th. https://www.astralcodexten.com/p/apply-for-an-acx-grant-2025
In this groundbreaking episode of Menopause Mastery, Dr. Betty Murray sits down with Dr. Daved Rosensweet—a physician with 55 years of experience who has been fighting for women's hormone rights since before most of us were born—to break down the game-changing FDA meeting that happened last week. For the first time in decades, the FDA is considering removing the black box warning from estrogen that has terrorized women and doctors for over 20 years. Dr. Rosensweet calls it "the biggest healthcare mistake of our time," and he's not wrong—this false warning has kept millions of women from life-saving hormone therapy. But here's what the media isn't telling you: the science has ALWAYS shown that women on hormones have LESS risk of breast cancer, heart attack, and stroke than women who go untreated. Yes, you read that right—LESS risk, not more. Dr. Rosensweet and Dr. Betty dive deep into why compounding bioidentical hormones are the gold standard, how to find the right provider, and why every woman—regardless of age—deserves to investigate hormone therapy. They also tackle the controversial topic of testosterone for women and why it's not a "male hormone" but a human hormone essential for muscle preservation and brain health. What You'll Learn: -The real science behind hormone therapy and breast cancer risk -Why women who've HAD breast cancer are actually safer on hormones -The truth about compounding pharmacies vs. commercial hormones -Why symptom relief isn't enough—you need proper testing -How to find a qualified hormone specialist -Why it's never "too late" to start hormone therapy If you're tired of being scared away from the hormones your body desperately needs, this episode will give you the courage and knowledge to take back control of your health. Links: Menrva Telemedicine: https://gethormonesnow.com/ FREE Hormone Quiz: https://bit.ly/3wNJOec Living Well Dallas: https://www.livingwelldallas.com/ Hormone Reset: https://hormonereset.net/ Betty Murray Website: https://www.bettymurray.com/ Facebook: https://www.facebook.com/BettyAMurrayCN/ Instagram: https://www.instagram.com/drbettymurray/ Produced by Evolved Podcasting: https://www.evolvedpodcasting.com/ Connect with Dr. Betty Murray: Website: https://www.bettymurray.com/ Facebook: https://www.facebook.com/BettyAMurrayCN/ Instagram: https://www.instagram.com/bettymurray_phd/ Connect with Dr. Daved Rosensweet https://www.davedrosensweetmd.com/ https://www.linkedin.com/in/davedrosensweetmd/ Thank you for listening to Menopause Mastery. Empowering your health journey, one episode at a time.
A handful of encouraging signals is cause for cautious optimism for biotech headed into the second half of the year — companies have been able to parlay strong data into follow-on capital and M&A activity is picking up. That said, the IPO market continues to be closed and concerns about U.S. drug pricing and FDA stability continue to weigh on expectations for a robust near-term sector recovery.Special guest Megan Hooton from IQVIA Biotech joins BioCentury's analysts on a special edition of the podcast to discuss key indicators of progress for the biopharma sector. Hooton is president of IQVIA Biotech, which sponsored this episode of the pod.View full story: https://www.biocentury.com/article/656614#biotech #biopharma #pharma #lifescience #BiotechTrends #ClinicalTrials #GeneTherapy #CellTherapy00:01 – Sponsor Message: IQVIA Biotech02:37 – Biotech Markets06:41 – Clinical Highlights10:26 – Insights from Meg Hooton23:10 – Advanced TherapiesTo submit a question to BioCentury's editors, email the BioCentury This Week team at podcasts@biocentury.com.Reach us by sending a text
Dr. Jim Keany, Chief Medical Officer at Dignity Health St. Mary Medical Center in Long Beach, joins The Bill Handel Show for 'Medical News'! Dr. Keany talks with Bill about a study that has shown The Pandemic aged our brains faster, how many steps you need daily to combat diabetes, and prescription fluoride facing FDA scrutiny.
“There's research that says over 50% percent of supplements tested weren't exactly what they claimed to be.”Friend, your mind is about to explode in Part 2 of our chat with Dr. Jessica Knurick!We chat about why the wellness industry has exploded in recent years and the changes we can make to keep ourselves (and our neighbors) healthy.Dr. Jessica breaks down why supplements aren't regulated by the FDA and how our government's policies have resulted in a lack of accessibility to nutritious food and preventive healthcare for many Americans.I had to ask her if eating whole foods and moving your body was enough to stay healthy and you may be surprised by her answer.Thanks for being here with an open mind! And don't miss Part 1 when Dr. Jessica talks about ultra-processed food and why we should care about public health in the first place.Get the rest of the links and resources from this chat at https://nicolewalters.com/episode508And WATCH this chat on YouTube at https://nicolewalters.com/youtubeEpisode Sponsors:Use code WALTERS at checkout for 15% off your entire order at www.vionicshoes.com when you log into your account. 1 time use only.Head to ByHeart.com and use code NICOLE30 to save 30% off your first subscription order for a limited time.Produced by Dear MediaSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
Annie's secret is an epic tale of an unexpected friendship. At the heart of it is her 70-year-old gynecologist—a man she trusted, only to discover he had committed fertility fraud. What began as a complicated yet heartfelt bond spiraled into a whirlwind of emotions, ending in a tragedy that changed everything. HERS Thank you, HERS! forhers.com/SECRET for your personalized weight loss treatment options. Hers Weight Loss by Hers is not available everywhere. Compounded products are not approved or reviewed for safety, effectiveness, or quality by the FDA. Prescription required. See website for full details, important safety information, and restrictions. Actual price depends on product and plan purchased. PICTURES See the painting, Annie and Doc at the aquarium, Annie's paper airplane tattoo and the braided bracelet. They are waiting for you on Threads, Facebook, Instagram and X. Handle: @secretroompod. THE SECRET ROOM | UNLOCKED Remember our recent episode Pee Freeze where Lauren told the hilarious secret of outwitting a drug test with the help of none other than her mom? In a can't miss follow up, Lauren's mom tells us her side of the story! And some of the questions came from listeners and from Lauren herself! Host: Susie Lark. The Secret Room | Unlocked is yours when you support your favorite indie podcast that could with a membership at patreon.com/secretroom, Apple Podcasts or Spotify. There's a free trial! ALL OUR SPONSORS See all our sponsors past and present, and their offers, many of which are still valid: secretroompodcast.com/codes FACEBOOK DISCUSSION GROUPThere's even more fun at The Secret Room Podcast Facebook Discussion Page! Just ask to join, all are welcome. :) YOUR SECRET Click "Share a Secret" at secretroompod.com! PODCAST TEAM Producer: Susie Lark. Story Development: Luna Patel. Music and Theme: Breakmaster Cylinder. LISTENER SURVEY Take our Listener Survey at SecretRoomPod.com!
Dr Steve, Dr Scott, and Lady Diagnosis discuss: What are Quercetin and Zinc used for? Can you use vascepa prophylactically? Quinine pills for leg cramps? Why was it banned by the FDA? A challenging hip pain and more Please visit: simplyherbals.net/cbd-sinus-rinse (the best he's ever made. Seriously.) instagram.com/weirdmedicine x.com/weirdmedicine stuff.doctorsteve.com (it's back!) youtube.com/@weirdmedicine (click JOIN and ACCEPT GIFTED MEMBERSHIPS. Join the "Fluid Family" for live recordings!) youtube.com/@normalworld (Check out Dave and crew, and occasionally see your old pal!) supertip.gg/drsteve (make your pals say awful things through the magic of AI) CHECK OUT THE ROADIE COACH stringed instrument trainer! roadie.doctorsteve.com (the greatest gift for a guitarist or bassist! The robotic tuner!) see it here: stuff.doctorsteve.com/#roadie Also don't forget: Cameo.com/weirdmedicine (Book your old pal right now because he's cheap! "FLUID!") Most importantly! CHECK US OUT ON PATREON! ALL NEW CONTENT! Robert Kelly, Mark Normand, Jim Norton, Gregg Hughes, Anthony Cumia, Joe DeRosa, Pete Davidson, Geno Bisconte, Cassie Black ("Safe Slut"). Stuff you will never hear on the main show ;-) Learn more about your ad choices. Visit podcastchoices.com/adchoices
Sheila Buswell is the CEO and Co-Founder of Buswell Biomedical, a veteran of the US Army, and the author of Is This Seat For Me? Overcoming Imposter Syndrome in Everyday Life and Business. In her book, Sheila shares her personal experiences overcoming sexism in engineering and tech and dealing with impostor syndrome, as well the stories of a diverse group of accomplished individuals who struggled with self-doubt but found ways to overcome it. She hopes to help others who feel limited by their beliefs experience more freedom and realize they are enough.
Ben Casavant, co-founder and CEO of Tasso, joins the show to discuss how he transformed the idea of patient-led blood collection into a reality through devices like Tasso+. He explains how Tasso's self-collection kits—designed to be easy, virtually painless, and used anytime at home—solve the scalability issues of mobile phlebotomy while improving patient convenience, adherence, and access to care. Casavant also details the company's growth journey, its FDA-cleared and CE-marked products, the broad customer base that includes healthcare providers, labs, insurers, and pharma companies, and how Tasso adds value not only through affordability, but by streamlining logistics, boosting compliance, and enabling seamless integration of patient-collected data into care systems. Read more about Tasso. https://www.tassoinc.com/ Check out Chadi's website for all Healthcare Unfiltered episodes and other content. www.chadinabhan.com/ Watch all Healthcare Unfiltered episodes on YouTube. www.youtube.com/channel/UCjiJPTpIJdIiukcq0UaMFsA
An Arizona woman is sentenced to eight years in prison for setting-up a North Korean “laptop farm” in her residence. Then, the Tallahassee, Florida police department thought it was a good idea to arrest a man suspected of credit card fraud at the local Chuck E Cheese. The suspect was taken into custody in full mouse costume while families enjoyed food and games. Finally, that Dairy Queen soft serve cone is not filled with ice cream. According to the FDA the milkfat content for ice cream is at least 10%. DQ has a milk fat content of only 5% so it cannot be called ice cream. Who knew? Apple Podcasts: apple.co/1WwDBrC Spotify: spoti.fi/2pC19B1 iHeart Radio: bit.ly/4aza5LW YouTube Music: bit.ly/43T8Y81 Pandora: pdora.co/2pEfctj YouTube: bit.ly/1spAF5a Also follow Tim and John on: Facebook: www.facebook.com/focusgroupradio
Hormone replacement therapy (HRT) shouldn't be shrouded in outdated fears and misinformation. When I finally started HRT at 57, I realized I'd spent years unnecessarily suffering through sleepless nights, hot flashes, and night sweats—chalked up to “normal aging”—when effective treatments already existed.My journey began after a hysterectomy, when a nurse practitioner discovered my testosterone level was critically low (11 ng/dl, with a normal range of 13–87). That led to my first experience with vaginal estrogen and topical testosterone. But over time, I learned I needed a more comprehensive approach—including systemic estrogen and progesterone—to truly feel like myself again.This episode also breaks down the recent FDA meeting that addressed two major barriers to women's hormone health:The outdated black box warning on vaginal estrogenThe ongoing lack of FDA-approved testosterone options for womenThese regulatory hurdles continue to block access to treatments that dramatically improve quality of life for midlife women.Whether you're working with your OB-GYN or exploring options through platforms like MyAlloy, MidiHealth, HerMD, or Parlor Games—support exists. But you must advocate for yourself. No woman should suffer in silence or settle for a life that feels like a shadow of her former self.Share this episode with someone who thinks they're “just getting older” and doesn't realize how good they could actually feel.Some Online Women's Health Resources:Allara Health, Midi Health, Alloy Women's Health, Evernow, Winona, HerMD, Femgevity, Maven ClinicThis episode is not intended to be medical advice. I'm sharing my personal journey with hormone replacement therapy in hopes of starting a conversation and helping other women feel less alone. I realize HRT is not the right fit for everyone._________________________________________Are you ready to reclaim your midlife body and health? I went through my own personal journey through menopause, the struggle with midsection weight gain, and feeling run-down. Faster Way, a transformative six-week group program, set me on the path to sustainable change. I'd love to work with you! Let me help you reach your health and fitness goals.https://www.fasterwaycoach.com/?aid=MicheleFolanHave questions about Faster Way? Please email me at:mfolanfasterway@gmail.com After trying countless products that overpromised and underdelivered, RIMAN skincare finally gave me real, visible results—restoring my glow, firmness, and confidence in my skin at 61. RIMAN Korea's #1 Skincare Line - https://michelefolan.riman.com*Transcripts are done with AI and may not be perfectly accurate.**This podcast is for general informational purposes only and does not constitute the practice of medicine, nursing, or other professional healthcare services, including the giving of medical advice. The content of this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Users should not disregard or delay in obtaining medical advice for any medical condition they may have and should seek the assistance of their healthcare professionals for any such conditions.
Is one outdated warning label standing between millions of women and safe, effective care? In this episode of BackTable Urology, Dr. Yahir Santiago-Lastra, a urologist specializing in female pelvic medicine and reconstructive surgery at UC San Diego, joins host Dr. Suzette Sutherland to discuss the black box warning on vaginal estrogen, its historical context, and the ongoing advocacy efforts to update outdated FDA guidelines. --- SYNPOSIS The conversation covers the importance of low-dose vaginal estrogen in treating genitourinary syndrome of menopause (GSM), the fear surrounding hormone therapy due to misinterpreted data from the Women's Health Initiative (WHI) study, and the inequities faced in women's health, particularly in the context of hormone replacement therapies. They discuss the legislative and advocacy strategies needed to enact change, emphasizing the role of professional societies, legislative efforts, patient advocacy, and industry support in overcoming the barriers to updating the black box warning. --- TIMESTAMPS 00:00 - Introduction03:43 - History Behind the Estradiol Black Box Warning13:44 - The FDA Citizen Petition18:18 - Gender Inequity in Medicine24:05 - The Role of Organizational Guidelines in Patient Advocacy28:51 - Vaginal Estrogen for Genitourinary Syndrome of Menopause (GSM)32:57 - Medicare Spending and Legislative Advocacy44:56 - Recap and Future Directions --- RESOURCES (TRAVERSE Trial) Cardiovascular Safety of Testosterone-Replacement Therapyhttps://www.nejm.org/doi/full/10.1056/NEJMoa2215025 Systemic or Vaginal Hormone Therapy After Early Breast Cancer: A Danish Observational Cohort Studyhttps://doi.org/10.1093/jnci/djac112 (ASCO Study) Use of local estrogen therapy among breast cancer patients in SEER-MHOS databasehttps://doi.org/10.1200/JCO.2025.43.16_suppl.578 Vaginal estrogen use in breast cancer survivors: a systematic review and meta-analysis of recurrence and mortality riskshttps://doi.org/10.1016/j.ajog.2024.10.054
Are low testosterone clinics helping men—or creating more harm than good?In this revealing episode, Dr. Geo is joined by Dr. Justin Dubin, a leading urologist and host of The Man Up Podcast, to pull back the curtain on the booming world of direct-to-consumer testosterone clinics.Together, they explore:The truth behind the rise of low-T clinicsWhat these businesses get right—and where they dangerously fall shortDr. Dubin's undercover study: 6 out of 7 clinics offered testosterone to men who didn't qualifyThe overlooked risks of infertility, heart issues, and priapismHow buzzwords like “optimization” may be misleading patientsWhat every man should ask before starting testosterone therapyIf you've been curious about TRT, overwhelmed by online advice, or simply want to make informed decisions about your hormonal health—this episode is for you.
Drs. Patel and Armstrong discuss how they are integrating FDA-approved therapies into geographic atrophy care. They share their perspectives on emerging treatments, including the potential for combination or staged approaches.
Send us a textDr. Bobby examines how legitimate medical treatments often get overextended into unproven health claims—why it happens, why it matters, and how to spot it.Building on last episode's theme of health hype, this installment digs into examples where therapies with real medical uses (like vitamin C, B12, hyperbaric oxygen, and stem cell therapy) are being promoted far beyond what the evidence supports. Dr. Bobby unpacks the flawed logic of “theory plus anecdote plus expert equals evidence” and explains why even well-intentioned health advice can go too far when it skips the evidence.You'll hear about the historical rise and modern misuse of vitamin C—from preventing scurvy to overstated claims of immune boosting. The episode dives into vitamin B12, which has real benefits for those with deficiencies but is often marketed as a cure-all without support. Hyperbaric oxygen therapy, which is FDA-approved for very specific conditions like carbon monoxide poisoning and diabetic ulcers, is another example—now advertised for fatigue, brain fog, and aging without strong data to back it. And stem cell therapy, which truly helps in leukemia and bone marrow failure, is being extended to treat everything from dementia to heart disease—despite the lack of proven efficacy in these areas.Dr. Bobby then addresses why this happens: patient desperation, the placebo effect, and the sheer momentum of what has been called “Big Wellness”—an industry now worth hundreds of billions. Social media only amplifies these trends, creating fear of missing out and distorting what counts as credible.To help listeners navigate this landscape, Dr. Bobby shares questions to ask when encountering bold health claims. Has the treatment been proven in your condition? Are there peer-reviewed studies in humans? What are the risks and costs—not just financially, but in delaying evidence-based care? Are the promoters benefiting from those beliefs?He encourages all of us to remain open-minded skeptics: curious, informed, and protective of both our health and our wallets.Takeaways: Ask whether the health claim is backed by solid evidence, not just theory and anecdote. Don't assume treatments with real uses are effective for everything they're marketed for. Before trying the latest therapy, ask: Is this proven for my condition, and what's the real cost?
It's human nature to reduce and simplify complex situations. We like to think that weight loss is as simple as a formula like “calories in, calories out,” or that making better health choices is as easy as harnessing your willpower. The truth is that our bodies, minds, and behaviors are much more nuanced. And when it comes to our health, we often overlook the vital role that our environment and culture play. On this episode of The Model Health Show, you're going to hear my interview with Dr. Darshan Shah on the Extend Podcast. In this conversation, you're going to learn how your culture can influence your decisions and the fascinating science behind shared family meals. You'll also learn about the uptick in ultra-processed food consumption, why so many folks struggle to lose weight today, and my best tips for creating a family culture of health, connection, and unity. This conversation is full of important insights we can all apply, from making steps toward a more connected family culture, eating more whole foods, and cultivating better health in your home. So just click play and enjoy the show! In this episode you'll discover: How your environment influences your decisions. (12:20) The definition of culture. (13:00) Why our relationship with food is deeply intimate. (16:40) How the rates of processed food consumption have risen in recent decades. (20:50) Which food can reduce neuroinflammation. (25:51) The benefits of personalized nutrition. (30:47) A conversation on the FDA and red dye in the food supply. (32:49) How to create a healthy microculture within your home. (35:23) What post-ingestive feedback is. (49:41) A surprising connection between nutrient deficiencies, hunger, and obesity. (51:07) The problem with the idea of calories in, calories out. (56:10) How having a shared meal can benefit your physical and mental health. (1:04:35) Four tips to make family meals fun and engaging. (1:11:07) The minimum amount of times per week to share a meal with your children. (1:14:15) Items mentioned in this episode include: Levels.link/model - Join today and get 2 FREE months with a one-year membership! DrinkLMNT.com/model - Get a FREE sample pack of electrolytes with any order! Eat Smarter Family Cookbook - Transform the health, fitness, and connection of your entire family with the Eat Smarter Family Cookbook! Extend Podcast - Listen to more of Dr. Darshan Shah's interviews! Be sure you are subscribed to this podcast to automatically receive your episodes: Apple Podcast Spotify Soundcloud Pandora YouTube This episode of The Model Health Show is brought to you by Levels and LMNT. Learn how food affects your health with a continuous glucose monitor (CGM) from Levels. Join today at levels.link/model and get 2 free months with a one-year membership! Head to DrinkLMNT.com/model to claim a FREE sample pack of electrolytes with any purchase.
OpenAI prepares to launch GPT-5 in August Trump's AI Action Plan Is a Crusade Against 'Bias'—and Regulation UN tech chief pleads for global AI regulatory cooperation Trump, who promised to save TikTok, threatens to shut down TikTok Google AI Mode has 100M users, 2.5 Pro & Deep Search rolls out FDA's New Drug Approval AI Is Generating Fake Studies: Report Tesla is set to face off with the California DMV over claims it exaggerated Autopilot's and FSD's capabilities and misled consumers, in a five-day Oakland trial Google, Microsoft say Chinese hackers are exploiting SharePoint zero-day A look at Tea, a woman-only safety app with 4M users that lets users anonymously assign red or green flags to local men, as it goes viral with 900K new signups People in the UK now have to take an age verification selfie to watch porn online Intel is laying off tens of thousands and cancelling factories AMD CEO Sees Chips From TSMC's US Plant Costing 5%-20% More Spotify Publishes AI-Generated Songs From Dead Artists Without Permission DJI couldn't confirm or deny it disguised this drone to evade a US ban FCC approves Skydance-Paramount merger Gwyneth Paltrow is the new face of a kiss-cam tech scandal Julian LeFay, 'Father of The Elder Scrolls,' Has Died Aged 59 Tom Lehrer, Musical Satirist With a Dark Streak, Dies at 97 Host: Leo Laporte Guests: Molly White, Janko Roettgers, and Jacob Ward Download or subscribe to This Week in Tech at https://twit.tv/shows/this-week-in-tech Join Club TWiT for Ad-Free Podcasts! Support what you love and get ad-free shows, a members-only Discord, and behind-the-scenes access. Join today: https://twit.tv/clubtwit Sponsors: smarty.com/twit zscaler.com/security expressvpn.com/twit uscloud.com spaceship.com/twit
OpenAI prepares to launch GPT-5 in August Trump's AI Action Plan Is a Crusade Against 'Bias'—and Regulation UN tech chief pleads for global AI regulatory cooperation Trump, who promised to save TikTok, threatens to shut down TikTok Google AI Mode has 100M users, 2.5 Pro & Deep Search rolls out FDA's New Drug Approval AI Is Generating Fake Studies: Report Tesla is set to face off with the California DMV over claims it exaggerated Autopilot's and FSD's capabilities and misled consumers, in a five-day Oakland trial Google, Microsoft say Chinese hackers are exploiting SharePoint zero-day A look at Tea, a woman-only safety app with 4M users that lets users anonymously assign red or green flags to local men, as it goes viral with 900K new signups People in the UK now have to take an age verification selfie to watch porn online Intel is laying off tens of thousands and cancelling factories AMD CEO Sees Chips From TSMC's US Plant Costing 5%-20% More Spotify Publishes AI-Generated Songs From Dead Artists Without Permission DJI couldn't confirm or deny it disguised this drone to evade a US ban FCC approves Skydance-Paramount merger Gwyneth Paltrow is the new face of a kiss-cam tech scandal Julian LeFay, 'Father of The Elder Scrolls,' Has Died Aged 59 Tom Lehrer, Musical Satirist With a Dark Streak, Dies at 97 Host: Leo Laporte Guests: Molly White, Janko Roettgers, and Jacob Ward Download or subscribe to This Week in Tech at https://twit.tv/shows/this-week-in-tech Join Club TWiT for Ad-Free Podcasts! Support what you love and get ad-free shows, a members-only Discord, and behind-the-scenes access. Join today: https://twit.tv/clubtwit Sponsors: smarty.com/twit zscaler.com/security expressvpn.com/twit uscloud.com spaceship.com/twit
OpenAI prepares to launch GPT-5 in August Trump's AI Action Plan Is a Crusade Against 'Bias'—and Regulation UN tech chief pleads for global AI regulatory cooperation Trump, who promised to save TikTok, threatens to shut down TikTok Google AI Mode has 100M users, 2.5 Pro & Deep Search rolls out FDA's New Drug Approval AI Is Generating Fake Studies: Report Tesla is set to face off with the California DMV over claims it exaggerated Autopilot's and FSD's capabilities and misled consumers, in a five-day Oakland trial Google, Microsoft say Chinese hackers are exploiting SharePoint zero-day A look at Tea, a woman-only safety app with 4M users that lets users anonymously assign red or green flags to local men, as it goes viral with 900K new signups People in the UK now have to take an age verification selfie to watch porn online Intel is laying off tens of thousands and cancelling factories AMD CEO Sees Chips From TSMC's US Plant Costing 5%-20% More Spotify Publishes AI-Generated Songs From Dead Artists Without Permission DJI couldn't confirm or deny it disguised this drone to evade a US ban FCC approves Skydance-Paramount merger Gwyneth Paltrow is the new face of a kiss-cam tech scandal Julian LeFay, 'Father of The Elder Scrolls,' Has Died Aged 59 Tom Lehrer, Musical Satirist With a Dark Streak, Dies at 97 Host: Leo Laporte Guests: Molly White, Janko Roettgers, and Jacob Ward Download or subscribe to This Week in Tech at https://twit.tv/shows/this-week-in-tech Join Club TWiT for Ad-Free Podcasts! Support what you love and get ad-free shows, a members-only Discord, and behind-the-scenes access. Join today: https://twit.tv/clubtwit Sponsors: smarty.com/twit zscaler.com/security expressvpn.com/twit uscloud.com spaceship.com/twit
Food and Drug Administration Commissioner Martin Makary is getting lobbied by the MAHA movement to restrict food dyes and ultra-processed foods, as well as by the food, agriculture and pharmaceutical industries to reduce government oversight. “We want to go bold and there are a lot of things to do,” Makary tells POLITICO's Dasha Burns. “But we also want to find common ground and work incrementally.” At the same time, he says, “The amount of pressure I feel from industry or other branches of government is zero.” Makary also discusses how the agency is addressing women's health and access to mifepristone, what he calls a “child vaping epidemic,” and explains the rationale behind FDA staffing cuts as well as some controversial hires. Plus, White House reporter Jake Traylor joins Burns to discuss the mood inside the White House amid the fallout over the Jeffrey Epstein story, why President Trump is “itching” to get back on the campaign trail ahead of the 2026 midterms and whether GOP candidates in swing districts will welcome him. Learn more about your ad choices. Visit megaphone.fm/adchoices
© 2020-2025 Ivy Podcast Discovery LLC
